CB vs LAB
Chubb Ltd (CB) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CB and LAB stock pages for the full models.
Not investment advice.